Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-01

Clinical Trial Update: Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing preservative-free dexamethasone 0.1% and diclofenac 0.1% eye drops versus preserved formulations after cataract surgery is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dicloabak (diclofenac 0.1%)
  • Maxidex (dexamethasone 0.1%)
  • Monofree Dexamethason (dexamethasone 0.1%)
  • Voltaren Ophtha (diclofenac 0.1%)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Age-related Cataract | Phase 4 | Status: RECRUITING